Cano Health (NYSE:CANO) Stock Rating Lowered by UBS Group
Cano Health (NYSE:CANO) Stock Rating Lowered by UBS Group
UBS Group lowered shares of Cano Health (NYSE:CANO – Get Rating) from a buy rating to a neutral rating in a research note released on Friday morning, MarketBeat reports. They currently have $1.25 target price on the stock, down from their previous target price of $12.00.
瑞銀集團下調股份 卡諾健康 (紐約證券交易所:CANO — 獲得評分) MarketBeat 報導，從購買評級到週五早上發布的研究報告中的中性評級。他們目前的股票目標價格為 1.25 美元，低於之前的目標價 12.00 美元。
Several other equities research analysts have also issued reports on CANO. Cowen lowered shares of Cano Health from an outperform rating to a market perform rating and lowered their price target for the company from $10.00 to $3.00 in a report on Thursday, November 10th. Raymond James downgraded shares of Cano Health from an outperform rating to a market perform rating in a research note on Thursday, November 10th. Wolfe Research downgraded shares of Cano Health from an outperform rating to a peer perform rating in a research note on Thursday, January 5th. Credit Suisse Group reduced their target price on shares of Cano Health to $4.00 in a research note on Monday, November 28th. Finally, Cowen downgraded shares of Cano Health from an outperform rating to a market perform rating and reduced their target price for the company from $10.00 to $3.00 in a research note on Thursday, November 10th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of Hold and an average target price of $4.08.
其他多位股票研究分析師亦發表了有關 CANO 的報告。在 11 月 10 日（星期四）的一份報告中，科恩將卡諾健康的股票從「跑贏大市」評級降至市場表現評級，並將公司的目標價格從 10.00 美元降至 3.00 美元。雷蒙德詹姆斯降級卡諾健康的股票從跑贏大市場進行評級在研究報告上週四, 11 月 10 日.沃爾夫研究降級卡諾健康的股份從一個超越評級到同行執行評級在研究筆記上週四, 1 月 5 日.瑞信集團在 11 月 28 日星期一的研究報告中將卡諾健康股票的目標價格降至 4.00 美元。最後，在 11 月 10 日（星期四）的研究報告中，Cowen 將卡諾健康的股票從「表現大市」評級降至市場表現評級，並將該公司的目標價格從 10.00 美元降至 3.00 美元。兩位研究分析師對該股票進行了賣出評級，七人給出了持有評級，其中一位向該股發出了買入評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為「持有」，平均目標價為 4.08 美元。
Cano Health Trading Up 13.2 %
卡諾健康交易上升 13.2%
Shares of Cano Health stock opened at $1.20 on Friday. The firm has a market capitalization of $593.38 million, a PE ratio of -3.16 and a beta of 0.15. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.64 and a quick ratio of 1.64. The company's fifty day moving average price is $1.83 and its two-hundred day moving average price is $4.66. Cano Health has a 52-week low of $0.98 and a 52-week high of $9.75.
卡諾健康股票的股票上週五以 $1.20 開盤。該公司的市值為 59338 萬美元，私募股權比率為 -3.16，測試值為 0.15。該公司的債務與權益比率為 1.17，流動比率為 1.64，快速比率為 1.64。該公司的五十天移動平均價格為 1.83 美元，其 200 天移動平均價格為 4.66 美元。卡諾健康的 52 周低點為 0.98 美元，52 周高點為 9.75 美元。
Institutional Inflows and Outflows
機構流入和流出
Several institutional investors and hedge funds have recently added to or reduced their stakes in CANO. Raymond James & Associates lifted its position in Cano Health by 12.1% during the 1st quarter. Raymond James & Associates now owns 125,611 shares of the company's stock worth $798,000 after buying an additional 13,593 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its position in Cano Health by 18.6% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 169,145 shares of the company's stock valued at $1,074,000 after purchasing an additional 26,550 shares during the period. Bank of New York Mellon Corp lifted its position in Cano Health by 19.2% during the 1st quarter. Bank of New York Mellon Corp now owns 78,241 shares of the company's stock valued at $497,000 after purchasing an additional 12,578 shares during the period. HighTower Advisors LLC acquired a new position in Cano Health during the 1st quarter valued at about $129,000. Finally, Allianz Asset Management GmbH acquired a new position in Cano Health during the 1st quarter valued at about $2,268,000. Institutional investors and hedge funds own 25.56% of the company's stock.
一些機構投資者和對沖基金最近增加或減少了他們在 CANO 的股份。雷蒙德詹姆斯 & 同事提升了在卡諾健康的地位 12.1% 在第一季度.雷蒙德·詹姆斯 & 聯營公司現在擁有該公司股票的 125,611 股價值 798,000 美元在上一季度額外購買 13,593 股。雷蒙德詹姆斯金融服務顧問公司. 提高了在卡諾健康的地位 18.6% 在第一季度.雷蒙詹姆斯金融服務顧問公司在此期間額外購買 26,550 股股票後，現在擁有該公司 169,145 股價值 1,074,000 美元的股票。紐約梅隆銀行在第一季度上升了 19.2％ 在卡諾健康的地位。紐約梅隆銀行在期內額外購買 12,578 股股份後，現擁有該公司股票價值 497,000 美元的 78,241 股股份。高塔顧問有限責任公司在第一季度收購了卡諾健康的新位置，價值約為 129,000 美元。最後，安聯資產管理有限公司於第一季度收購了嘉諾健康的新職位，價值約 2,268,000 美元。機構投資者和對沖基金擁有公司股票的 25.56％。
Cano Health Company Profile
卡諾健康公司簡介
(Get Rating)
(取得評分)
Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.
卡諾健康有限公司為其在美國和波多黎各的成員提供初級保健醫療服務。它擁有並經營由 Canopanorama 支持的醫療中心，該平台是一個由人群健康管理技術驅動的專有平台，可為其醫療中心的醫療保健提供者提供 360 度全方位的會員視圖，並獲得可行的見解，以改善醫療決策和成員參與度。
Featured Articles
特色文章
- Get a free copy of the StockNews.com research report on Cano Health (CANO)
- 3 Airline Stocks Taking Off in 2023
- Why Wall Street Has Bullish Targets on Target Stock
- What Macy's Guidance Means For Retail
- Fortinet Stock Price Bumpy, Here Is Why
- Apexigen Stock Soars After Analyst Rating, Is It Time to Buy?
- 免費獲取有關長野健康的研究報告
- 3 家航空公司股票在 2023 年起飛
- 為什麼華爾街對目標股票有看漲目標
- 梅西百貨指南對零售意味著什麼
- Fortinet 股價顛簸，這就是為什麼
- APEXIGEN 股票在分析師評級後飆升，是時候買入了嗎？
Receive News & Ratings for Cano Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cano Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收有關卡諾健康日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Cano Health 及相關公司的最新新聞和分析師評級的簡明每日摘要。